Waldencast plc

WALD

Explore Our Financial Data > Companies > Waldencast plc

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	WALD
CIK	0001840199
SIC	2844
Sector	Manufacturing
Industry Category	Consumer Goods
Industry Group	Perfumes, Cosmetics And Other Toilet Preparations

Contact

Address	81 FULHAM ROAD, LONDON, X0, SW3 6RD
Website	waldencast.com
Phone	(917) 546-6828
CEO	Michel Brousset
Employees	N/A

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$273.87 million
Pre-Tax Income	$-48.54 million
Net Income	$-48.65 million
Net Income to Common	$-42.44 million
EPS	$-0.39

View All

Balance Sheet

Cash	$14.80 million
Assets	$975.86 million
Liabilities	$245.92 million
Common Equity	$662.32 million
Liabilities & Equity	$975.86 million

View All

Cash Flow Statement

Net Income	$-48.65 million
Cash From Operating Activities	$-8.82 million
Cash From Investing Activities	$-2.92 million
Cash From Financing Activities	$5.58 million
Change in Cash	$-6.16 million

View All

Calculations

NOPAT	$-41.01 million
EBITDA	$24.49 million
Price to Earnings	N/A
Price to Book	$0.42
ROE	-6.49%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Waldencast price target lowered to $4 from $5 at Telsey Advisory

Telsey Advisory analyst Dana Telsey lowered the firm’s price target on Waldencast (WALD) to $4 from $5 and keeps an Outperform rating on the shares. While not entirely unexpected, FY25 has started out relatively challenging, the analyst tells investors. While margin and distribution expansion opportunities exist for its Milk Makeup brand, the firm is moderating its price target given incremental risks to the global macro outlook. Published first on TheFly – the ultimate source for real-time, mar

Article Link

Waldencast Sees Improvement of 10 bps in Adjusted Gross Margin

By Daniella Parra Waldencast plc (Nasdaq: WALD) said net revenue decreased 4.1% year-over-year to $65.4 million and adjusted gross profit totaled $50.0 million, or 76.4% of net revenue, an expansion of 10 basis points compared to the prior year. Adjusted EBITDA was $4.4 million, or 6.7% of net revenue as the YOY decline was from […]

Article Link

Waldencast Reports Q1 2025 Financial Results

Q1 Net Revenue of $65.4 million, (4.1)% decline from Q1 202476.4% Adjusted Gross Margin, an improvement of 10 basis points$4.4 million of Adjusted EBITDA LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended March 31, 2025 (“Q1 2025”) on Form 6-K to the U.S. Securities and Exchange Commission (the “SEC”), which are also available on our

Article Link

Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast

LONDON, May 06, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its First Quarter Fiscal 2025 conference call and webcast. As previously announced, the Company will issue its First Quarter Fiscal 2025 results on May 13, 2025 after the close of the U.S. market. Management will host a conference call to discuss its First Quarter Fiscal 2025 results on May 14, 2025 at 8:30am ET. Investors and analysts

Article Link

Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream

A Scientific Breakthrough in Skin Renewal: A Clinically Proven Dual-Action, Slow-Release, Overnight Skin Renewal Cream for a Resurfaced, Smoother, and More Even-Looking Complexion NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Obagi Medical ("Obagi"), the fastest-growing professional skincare brand in the U.S. in 2024* and a subsidiary of Waldencast plc, (NASDAQ: WALD) (“Waldencast”), proudly introduces its latest breakthrough: Retinol + PHA Refining Night Cream. This advanced formulation is engin

Article Link